Vitrolife: Clinical Study with Good Results Using STEEN Solution(TM) Published in Prestigious Scientific Journal
Vitrolife AB (publ) (STO:VITR) In a landmark study recently published in the New England Journal of Medicine (www.nejm.org), surgeons at Toronto General Hospital reported one-year outcomes of patients transplanted with initially rejected donor lungs after ex vivo lung perfusion using STEEN Solution™. The most recent hospital to use the method is Sahlgrenska University Hospital in Gothenburg, Sweden.